Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sondermann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Clinical Immunology|April 4, 2016
The FcγR/IgG Interaction as Target for the Treatment of Autoimmune DiseasesPeter Sondermann
Immunology Letters|May 15, 2002
The structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitorsPeter Sondermann, Vaughan Oosthuizen
Acta Crystallographica. Section D, Biological Crystallography|December 4, 2003
Purification, crystallization and X-ray diffraction analysis of the extracellular part of the human Fc receptor for IgA, FcalphaRI (CD89)Katja Wenig, Peter Sondermann
Current Opinion in Immunology|April 3, 2016
Harnessing Fc receptor biology in the design of therapeutic antibodiesPeter Sondermann, David E Szymkowski
Proteomics|March 5, 2004
Determination of the stoichiometry of protein complexes using liquid chromatography with fluorescence and mass spectrometric detection of fluorescently labeled proteolytic peptidesElisabeth O Hochleitner, Peter Sondermann, Friedrich Lottspeich
The Journal of Biological Chemistry|December 7, 2005
The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoformsClaudia Ferrara, Fiona Stuart, Peter Sondermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated FcPeter Sondermann, Andrew Pincetic, Jad Maamary, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2013
General mechanism for modulating immunoglobulin effector functionPeter Sondermann, Andrew Pincetic, Jad Maamary, et al.
Molecular Immunology|May 17, 2011
Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodiesAlfred Schnueriger, Roger Grau, Peter Sondermann, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2008
Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIbSofia E Magnusson, Maria Andrén, Kajsa E Nilsson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Clinical Immunology|April 4, 2016
The FcγR/IgG Interaction as Target for the Treatment of Autoimmune DiseasesPeter Sondermann
Immunology Letters|May 15, 2002
The structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitorsPeter Sondermann, Vaughan Oosthuizen
Acta Crystallographica. Section D, Biological Crystallography|December 4, 2003
Purification, crystallization and X-ray diffraction analysis of the extracellular part of the human Fc receptor for IgA, FcalphaRI (CD89)Katja Wenig, Peter Sondermann
Current Opinion in Immunology|April 3, 2016
Harnessing Fc receptor biology in the design of therapeutic antibodiesPeter Sondermann, David E Szymkowski
Proteomics|March 5, 2004
Determination of the stoichiometry of protein complexes using liquid chromatography with fluorescence and mass spectrometric detection of fluorescently labeled proteolytic peptidesElisabeth O Hochleitner, Peter Sondermann, Friedrich Lottspeich
The Journal of Biological Chemistry|December 7, 2005
The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoformsClaudia Ferrara, Fiona Stuart, Peter Sondermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated FcPeter Sondermann, Andrew Pincetic, Jad Maamary, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2013
General mechanism for modulating immunoglobulin effector functionPeter Sondermann, Andrew Pincetic, Jad Maamary, et al.
Molecular Immunology|May 17, 2011
Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodiesAlfred Schnueriger, Roger Grau, Peter Sondermann, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2008
Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIbSofia E Magnusson, Maria Andrén, Kajsa E Nilsson, et al.
Pageof 2